Seres Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Seres Therapeutics, Inc. (MCRB) had Lessee, Operating Lease, Liability, to be Paid, Year One of $19.02 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $19.02M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $20.58M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $19.98M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $19.98M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $19.02M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $20.58M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $19.98M 10-K · filed 2026-03-12 |
| 2025-09-30 | $19.98M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $19.98M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $19.98M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $19.44M 10-K · filed 2025-03-13 |
| 2024-09-30 | $19.44M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $22.06M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $22.06M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $19.87M 8-K · filed 2024-08-15 |
| 2023-09-30 | $19.44M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $19.44M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $19.05M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $16.82M 10-K · filed 2023-03-07 |
| 2022-09-30 | $2.39M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $4.39M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $5.64M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $8.51M 10-K · filed 2022-03-01 |
| 2020-12-31 | $6.46M 10-K · filed 2021-03-02 |
| 2019-12-31 | $6.30M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |